|
| Rivaroxaban (Xarelto®) | Dalteparin Sodium (Fragmin®) | ||||
| Positive | Negative | p-value | Positive | Negative | p-value | |
| Patients, n (P/Ca) | 17 (11.3%) | 133 (88.7%) |
| 18 (12.0%) | 132 (88.0%) |
|
| Age, yr (range) | 68 (51 - 88) | 69 (53 - 88) | 1.000 | 69 (61 - 77) | 70 (58 - 86) | 0.822 |
| Gender, M:F | 4:13 | 12:121 | 0.068 | 4:14 | 18:114 | 0.334 |
| BMIb, kg/m2 (range) | 25 (17 - 31) | 26 (18 - 37) | 0.156 | 26 (14 - 32) | 26 (16 - 34) | 0.990 |
| Unilateral TKA, n (P/Ca) | 6 (11.8%) | 45 (88.2%) | 0.905 | 8 (12.7%) | 55 (87.3%) | 0.154 |
| Bilateral TKA, n (P/Ca) | 11 (11.1%) | 88 (88.9%) | 10 (11.5%) | 77 (88.5%) | ||
| Diabetes, n (P/Ca) | 2 (11.8%) | 31 (23.3%) | 0.279 | 3 (16.7%) | 30 (22.7%) | 0.560 |
| Hypertension, n (P/Ca) | 9 (52.9%) | 93 (69.9%) | 0.157 | 11 (61.1%) | 88 (66.7%) | 0.641 |
| Hyperlipidemia, n (P/Ca) | 3 (17.6%) | 43 (32.3) | 0.216 | 3(16.7%) | 35 (26.5%) | 0.367 |
| Smoking, n (P/Ca) | 0 (0.0%) | 1 (0.8%) | 0.720 | 0 (0.0%) | 1 (0.8%) | 0.711 |
| History of lower limb surgery, n (P/Ca) | 4 (23.5%) | 31 (23.3%) | 0.768 | 7 (38.9%) | 29 (22.0%) | 0.214 |